1Johnson MP, Michaelson JE, Barr JM, et al. Combining humerus and femur length for improved ultrasonographic identification of pregnancies at increased risk for trisomy 21. Am J Obstet Gynecol,1995,172(4 Pt 1):1229-1235.
2Benacerraf BR, Harlow B, Frigoletto FD. Hypoplasia of the middle phalanx of the fifth digit: a feature of the second trimester fetus with Down syndrome. J Ultrasound Med, 1990,9(7):389-394.
3Khoshnood B, De Vigan C, Vodovar V, et al. A population-based evaluation of the impact of antenatal screening for Down's syndrome in France, 1981-2000. Br J Obstet Gynecol, 2004,111(5):485-490.
4Papp Z, Fekete T. The evolving role of ultrasound in obstetrics/gynecology practice. Int J Gynaecol Obstet, 2003,82(3):339-346.
5Berman MC, Cohen HL. Obstetrics and gynecology: diagnostic medical sonography. 2nd ed. Philadelphia: JB Lippincott, 1997.211-357.
6Zoppi MA, Ibba RM, Floris M,et al. Nuchal translucency measurement at different crown-rump lengths along the 10- to 14-week period for Down syndrome screening. Prenat Diagn,2005,25(5):411-416.
7Orlandi F, Rossi C, Orlandi E,et al. First-trimester screening for trisomy-21 using a simplified method to assess the presence or absence of the fetal nasal bone. Am J Obstet Gynecol, 2005,192(4):1107-1111.
8Watson WJ, Miller RC, Menard K, et al. Ultrasonographic measurement of fetal nuchal skin to screen for chromosomal abnormalities. Am J Obstet Gynecol,1994,170(2):583-586.
9Berlin BM, Norton ME, Sugarman EA,et al. Cystic fibrosis and chromosome abnormalities associated with echogenic fetal bowel. Obstet Gynecol, 1999,94(1):135-137.
